share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Aug 8 11:49
Summary by Moomoo AI
Vertex Pharmaceuticals Inc. Director Sangeeta N. Bhatia is set to sell 1,292 shares of common stock on 08/08/2024, according to a recent filing. The shares, valued at an aggregate market price of $602,446.68, were originally acquired on the same date through options granted on 06/01/2018. The transaction will be conducted with cash as the nature of payment. No other sales of securities have been reported by Bhatia in the past three months.
Vertex Pharmaceuticals Inc. Director Sangeeta N. Bhatia is set to sell 1,292 shares of common stock on 08/08/2024, according to a recent filing. The shares, valued at an aggregate market price of $602,446.68, were originally acquired on the same date through options granted on 06/01/2018. The transaction will be conducted with cash as the nature of payment. No other sales of securities have been reported by Bhatia in the past three months.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more